ThomasBoydMD

PubMed

• 8 citations
  A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluor...
  Tracy Murray Stewart, Daniel D. Von Hoff, Michael L. Fitzgerald, Laurence J. Marton, Thomas E. Boyd, Paul Conkling, Lawrence Garbo, Robert M. Jotte, Donald A. Richards...> ;Cancer Chemotherapy and Pharmacology. 2021 Jan 1
• 37 citations
  A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
  Sumanta K. Pal, Andres Forero-Torres, John A. Thompson, John C. Morris, Saurabh Chhabra, Christopher J. Hoimes, Nicholas J. Vogelzang, Thomas E. Boyd, Paulo Gustavo Be...> ;Cancer. 2019 Apr 1
• 46 citations
  A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.
  Tycel Phillips, Paul M. Barr, Steven I. Park, Kathryn S. Kolibaba, Paolo Caimi, Saurabh Chhabra, Edwin C. Kingsley, Thomas E. Boyd, Robert T. Chen, Anne Sophie Carret,...> ;Investigational New Drugs. 2019 Apr 1
• 17 citations
  CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia.
  Guillermo Garcia-Manero, Bart L. Scott, Christopher R. Cogle, Thomas E. Boyd, Suman Kambhampati, Joel Hetzer, Qian Dong, Keshava Kumar, Stacey M. Ukrainskyj, C.L. Beac...> ;Leukemia Research. 2018 Sep 1
• 11 citations
  Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia.
  Steven Coutre, Ian W. Flinn, Sven de Vos, Jacqueline C. Barrientos, Marshall T. Schreeder, Nina Wagner-Johnson, Jeff P. Sharman, Thomas E. Boyd, Nathan Fowler, Lyndah ...> ;Hemasphere. 2018 Apr 25
• 31 citations
  Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases.
  Costantine Albany, Lawrence H. Einhorn, Lawrence Garbo, Thomas E. Boyd, Neil C Josephson, Darren R. Feldman> ;The Oncologist. 2018 Mar 1
• 88 citations
  Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial
  Rami S. Komrokji, Guillermo Garcia-Manero, Lionel Ades, Thomas Prebet, David P. Steensma, Joseph G. Jurcic, Mikkael A. Sekeres, Jesus G. Berdeja, Michael R. Savona, Od...> ;The Lancet. Haematology. 2018 Feb 1
• 14 citations
  Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma.
  Sven de Vos, Nina D. Wagner-Johnston, Steven Coutre, Ian W. Flinn, Marshall T. Schreeder, Nathan Fowler, Jeff P. Sharman, Ralph V. Boccia, Jacqueline C. Barrientos, Ka...> ;Blood Advances. 2016 Dec 13
• 45 citations
  Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer
  Giorgio V. Scagliotti, Jin Hyoung Kang, David J. Smith, Richard K. Rosenberg, Keunchil Park, Sang We Kim, Wu Chou Su, Thomas E. Boyd, Donald A. Richards, Silvia Novell...> ;Investigational New Drugs. 2016 Jun 27
• 217 citations
  Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.
  Heather H. Cheng, Colin C. Pritchard, Thomas Boyd, Peter S. Nelson, Bruce Montgomery> ;European Urology. 2016 Jun 1
• 28 citations
  Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
  Christopher R. Cogle, Bart L. Scott, Thomas E. Boyd, Guillermo Garcia-Manero> ;The Oncologist. 2015 Dec 1
• Join now to see all